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Competition in the Dutch Health Care System
Ed W.M.T. Westerhout ∗
Abstract
This paper describes the move towards a model of managed competition in
the Dutch health care system. Although important policy changes have been
implemented, a lot of work remains to be done. As regards managed care activities
by insurers and mobility of people between different sickness funds for example,
the results of policy changes thus far have been modest. The paper explains
the slow progress in terms of the preferences of Dutch policy makers to avoid cost
increases and prevent a reduction of the accessibility of medical care. Reforms will
not come to a halt however. Indeed, the ageing of the population will command
further reforms of the health care sector.
Introduction
The evolution of Dutch health care policies fits nicely in the framework proposed
by Cutler (2002). Whereas in the eighties policy makers tried to curb the con-
tinuous growth in health expenditure mainly by policies of regulation, in the
nineties the focus shifted more to introducing competitive elements in the health
care system. This is not to say that from then Dutch policies pursued a model of
pure competition: this would conflict with the principle of accessibility of medical
care, which is highly valued by Dutch policy makers. Rather, the policy reforms
aimed at introducing a model of regulated competition (Enthoven (1978, 1988))
in order to increase efficiency without sacrificing the solidarity between different
medical risks.
Typical for the Netherlands are two features. One is that whichever policies are
being introduced, they should not imply a risk of increasing health expenditure
(and health insurance premiums). The other is that policy reforms should not
∗. CPB Netherlands Bureau for Economic Policy Analysis. The author is affiliated with CPB Nether-
lands Bureau for Economic Policy Analysis, The Hague, and University of Amsterdam, Amsterdam. He
thanks Rudy Douven and Peter Kooiman for useful remarks on an earlier version of this paper. The
views expressed in this paper are not necessarily those of CPB.
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imply a (partial) privatization of health care. These two additional restrictions
may explain why the reform of the health care market in the Netherlands has
taken a long time up till now and why we should not expect dramatic changes in
policies or results in the coming years. The Dutch population is ageing like the
populations in so many other countries however, making ultimately a reform of
the health care system unavoidable. Because of the upward pressure on health
care costs that ageing brings about, ultimately policy makers cannot escape to
accept a lower degree of accessibility, either through increasing competition on
health insurance markets or a (partial) privatization of health insurance schemes.
This paper describes the ideas behind Dutch policies that aim to make health
care markets more competitive and how they have been put into practice. It
sketches that policy changes have been rather slow. This may reflect the fear
that more drastic policy changes would lead to a cost explosion or would severely
endanger the solidarity between different medical risks. It argues that the prospect
of ageing will unavoidably imply that health insurance contribution rates are
reduced, either by paying more attention to the efficient provision of health care
services or by privatizing part of health insurance.
The structure of this paper is as follows. Section 2 briefly describes the struc-
ture of Dutch health insurance schemes. Sections 3 and 4 discuss the policy
changes that have been implemented in the Netherlands and their effects on the
health insurance system. Section 5 adopts a political-economy perspective to
explain why the health care system has been reformed quite slowly. Section 6
concludes.
1. The Dutch health insurance scheme
This section discusses the Dutch health insurance scheme on a very global
level. 1 The scheme consists of three pillars. Basically, the first pillar (AWBZ) cov-
ers long-term care services 2, whereas the second pillar schemes cover expenditure
on short-term care services. 3 The relatively small third pillar covers services that
are considered to be more luxury. 4
The first-pillar insurance scheme is a public scheme with mandatory insur-
ance and is financed by a combination of income-dependent premiums and co-
payments. The second-pillar insurance scheme falls into three parts: a public
1. For a more detailed description, see Westerhout (1999).
2. This includes nursing home care, institutional care for mentally and physically handicapped
persons and hospital care exceeding one year.
3. This includes services by general practitioners, medical specialists and hospital care up to one
year.
4. This includes luxury hospital services , but also dental care for adult persons.
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scheme that is mandatory for those with income below a certain threshold (ZFW),
a set of voluntary private schemes for those with age below 65 who are not al-
lowed to join the public scheme and, finally, a voluntary public scheme for 65+
persons who are not allowed to join the ZFW (WTZ). Two types of community-
rated premiums finance the ZFW, namely income-dependent premiums and nom-
inal (i.e. income-independent) premiums. The private scheme draws on nominal
premiums in combination with co-payments (mostly deductibles). The WTZ is
financed by community-rated premiums and taxes. Third-pillar insurance is vol-
untary and, like the private second-pillar schemes, financed by a combination of
nominal premiums and co-payments.
The Dutch health insurance scheme is more public than private. Using 1997
figures, only about 12.5 % of health expenditure is covered by private schemes
and 87.5 % by public schemes. 5 The distinction between public and private is
not very informative about the organization of insurance schemes, however. For
a discussion of competitive elements in Dutch insurance schemes, the regulations
governing public and private insurance schemes are more relevant. Indeed, the
next section will show that although the ZFW scheme has always been regarded
a public scheme, it has undergone many transformations in the last 12 years.
2. The content of the policy reforms
Already in 1988, the Dutch government decided to move its health care system
towards a model of managed competition. The Dekker plan aimed at the intro-
duction of a national health insurance scheme, covering both long-term care and
health care services. The main reason to go for the model of managed competition
was that it promises cost reduction without hampering the accessibility of health
care. Behind this is the aim to limit the increases in health insurance contribution
rates. Income-dependent health insurance contributions distort the labour mar-
ket, just like income taxes do, and contribute to employment and output losses.
Obviously, (partial) privatization would be a way to reduce income-dependent
health insurance contribution rates. 6 However, this would conflict with the prin-
ciple of accessibility of medical care, a principle that is so highly valued in the
5. If the WTZ were characterized as a private scheme, then the share of private schemes would be
considerably larger: 19 rather than 12.5 %. Although the WTZ is administered by private insurers and
participation is voluntary, the WTZ scheme may better be viewed as a public scheme since premiums
are community-rated and acceptance is obligatory, just like in the two other public schemes, the AWBZ
and the ZFW.
6. The scope of public insurance can be reduced in a number of ways: by eliminating certain types
of medical care from insurance packages, by introducing co-payments or by introducing nominal
premiums.
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Netherlands, that privatization to a more than trivial degree has not occurred.
On one aspect, the Dekker plan failed immediately: policy makers abandoned
the idea to change the first and second pillar of health insurance simultaneously.
Instead, they decided to go for a stepwise reform, beginning with the ZFW, the
major public part of second-pillar health insurance. Up till now, schemes other
than this ZFW have been left unaffected. However, the current government will
introduce a basic insurance scheme in 2006, basically integrating the three parts
of second-pillar insurance and extending considerably the scope of the model of
managed competition (CPB (2003)).
The changes implemented in the ZFW scheme fall into four parts: the financ-
ing of the ZFW, policies reforming provider markets, price policies, and policies
reforming insurance markets. We will discuss the changes in these four parts
successively.
2.1. The financing of the ZFW
Traditionally, the sickness funds that administer the ZFW were reimbursed on a
retrospective basis. 1993 saw the introduction of a prospective payment scheme,
which aimed to create incentives for sickness funds for an efficient delivery of
medical services. This transformation was not a big bang, but occurred very
gradually. With the introduction of prospective payments, also a transfer scheme
was introduced that paid sickness funds an additional amount when their costs
exceeded the prospective payment amount. As this additional amount is a fraction
(between zero and one) of the excess of costs over the amount of prospective
payments, the new scheme is actually a mix of a prospective and a retrospective
scheme. Gradually, this fraction has been lowered from 97 % in 1993 to 47 %
in 2004, turning the payment scheme more and more into a pure prospective one
(Van de Ven et al. (2004)).
The prospective element of the new payment scheme includes corrections for
risk factors that are exogenous for sickness funds. There are two reasons for
this. First, it would be unfair if sickness funds that happened to have an under-
representation (over-representation) of bad risks to make profits (losses). Second,
sickness funds would have an incentive to reduce the quality of services they
provide to those insured for which they expect to make losses. Therefore, the
prospective element of the new payment scheme adjusted for risk factors such as
age and gender. Over time, the payment scheme has been changed frequently. In
particular, risk factors have been added in order to improve the risk adjustment
properties of the payment scheme. In 2001, the determination of prospective pay-
ments to individual sickness funds rests on age, gender, degree of urbanization,
insurance ground (e.g., whether the insured is a wage earner or an unemployment
no 14 - 2004 / 1
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benefit recipient) and type of care (e.g., outpatient care or inpatient care) (Lamers
et al. (2003)). In 2002, information derived from prescribed drug usage was added
to the set of risk adjusters (Van de Ven et al. (2004)).
2.2. Policies reforming provider markets
In 1992, the rule that stipulated that sickness funds should have a contract
with all providers of medical services in their region was abolished, but only for
the non-institutional providers like physiotherapists. For institutional providers
like hospitals, the intention is to do the same, but this has not been realized
yet. Also important for provider markets is that in 1998, a policy change has been
implemented that aims to strengthen competition policies in the Netherlands. This
policy change is general and thus is relevant for health care provider markets as
well.
Policies regulating the supply of medical care have remained largely un-
changed. Policies that restrict the number of persons that are allowed to study
medicine at university have been kept in place and provider organisations have
continued to self-regulate the market. Policies that regulate hospital capacity are
no longer un-discussed however. The current government is working on abolish-
ing regulations that dictate the investment decisions of hospitals.
2.3. Price policies
Before 1992, the prices for medical services were set by a central authority.
As part of the 1992 reforms, prices for services provided by non-institutional
providers were deregulated and the previous prices were transformed into maxi-
mum prices. For hospitals, there are plans to deregulate prices in the future. As
a first step, all medical services that are provided by hospitals have in the last
few years been classified under a DRG system. The next step will entail price
deregulation for 10 % of hospital production. But this has been postponed on two
occasions already with half a year.
2.4. Policies reforming insurance markets
Before 1992, sickness funds were regional monopolies: they could only enroll
those who lived in the area in which the fund was located. In 1992, this rule was
abolished, allowing sickness funds to compete for subscribers. First, enrollment
periods were bi-annual, but since 1997, they are annual.
économiepublique
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3. The results of the policy reforms
As shown in the previous section, financial incentives for sickness funds for
an efficient delivery of care have gradually increased over time. Yet, the mobility
of insurees across sickness funds has not increased significantly, despite the fact
that the variation in nominal premiums across sickness funds has increased con-
siderably. 7 As shown previously, policy reforms in other fields have been partial
and slow. In particular, policies regulating the supply of medical care have not
undergone significant changes. This has led to a shortage of supply in a number
of markets. That this undermines the bargaining power of insurance companies is
obvious.
Together, these factors may explain why we have seen few sickness funds
starting to undertake managed care activities. Sickness funds have not developed
policies to monitor the activities of doctors and have been reluctant to bargain
more aggressively about prices of medical services.
4. The benefits and costs
of managed competition
The model of managed competition may help to achieve a higher level of
efficiency than otherwise can be obtained. The model has some disadvantages
as well, though. One is that the risk adjustment in insurance payment schemes
will never be perfect. Although it is possible to eliminate a large part of the
variation on costs that are exogenous to insurance companies, full elimination
will never occur. This means that the payment scheme will always hurt those
companies that have an over-representation of bad risks and that incentives for
companies to lower the quality of services for these bad risks will remain (Douven
and Westerhout, (2000)). In particular, the incentives to lower the quality of
medical services are stronger the more prospective is the financing scheme for
sickness funds.
Another drawback is that if quality is poorly observed by the insured, insurers
have an incentive to reduce quality in order to economize on costs (Dranove and
Satterthwaite (2000)). The study of Propper et al. (2004) for the UK indeed found
a negative effect of competition on quality, be it that the effect was rather small.
The argument holds even more strongly if government policies make consumers
more price sensitive by increasing the transparency of insurance markets.
7. Schut and Hassink (2003) report that the standard deviation of the nominal premium increased
from 1.2 (compared to a mean of 0.6) in 1995 to 27.9 (compared to a mean of 7.0) in 1999.
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A third argument against managed competition is that the government does
no longer have direct control over the volumes and prices and therefore the level
of aggregate expenditure. The outcome of negotiations between insurers and
providers of medical services may be a lower or higher level of expenditure. In
particular, if there are few providers or if providers form cartels, insurance com-
panies may find it difficult to set good bargains and the outcome may be higher
aggregate health expenditure than under regulation policies.
The aim of the introduction of the model of managed competition in the
Netherlands is to obtain a higher level of efficiency, a lower level of aggregate
health expenditure and lower health insurance contribution rates. One can view
the slow evolution of the sickness fund financing scheme from a retrospective
scheme towards a prospective scheme as a reflection of the fear that insurers will
start making efforts to select good medical risks. The slow progress in making
insurance markets more transparent may similarly be explained from the fear that
this will increase the efforts undertaken by insurers to lower prices by reducing
quality. The reluctance of the government to deregulate supply policies may re-
flect the fear that an increase of supply will not be dominated by the effect on
the bargaining position of insurance companies and will therefore raise health
expenditure.
5. Concluding remarks
A number of factors may explain the slow progress towards making the health
care system in the Netherlands more competitive. Can we expect reforms to come
to a standstill? The answer is negative. In particular, ageing of the population in-
creases the attractiveness of policy reforms that aim at reducing the level of health
expenditure. Ageing will increase health care expenditure and reduce labour mar-
ket participation. Both factors contribute to the expectation of an increasing
health insurance contribution rate. Elsewhere, I have argued that this has three
effects (Westerhout (2004)). First, it aggravates labour market distortions. Second,
it aggravates a number of moral hazard distortions. Thirdly, increasing transfers
from young healthy generations to old and unhealthy generations jeopardizes in-
tergenerational solidarity. For all these reasons, it becomes more attractive to
reduce the level of health expenditure by bringing in more competitive elements
in health care schemes.
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